Company
Anebulo Pharmaceuticals, Inc. (ANEB)
Standardized SEC financial data for Anebulo Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001815974 · OTC · Pharmaceutical Preparations.
Return on equity
-72.8%
Free cash flow
-$6.3M
EPS (diluted)
$-0.25
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $2.3M | $3.0M | $5.6M | $3.5M | $4.3M |
| SG&A expense | $1.3M | $3.9M | $6.2M |
Standardized from Anebulo Pharmaceuticals, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | $11.2M | $3.1M | $11.6M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.9M | -$5.4M | -$9.7M | -$8.1M | -$6.3M |
| Financing cash flow | $21.8M | — |
Get ANEB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ANEB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ANEB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"